Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The gross margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
GROSS MARGIN
0.00%
GROSS MARGIN AVG TTM
0.00%
GROSS MARGIN AVG 3Y
0.00%
GROSS MARGIN AVG 5Y
N/A
GROSS MARGIN AVG 10Y
N/A
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
39.32%
median of 683 covered companies
CURRENT VS SECTOR MEDIAN
-100.00%
vs the sector median at left
Cadrenal Therapeutics, Inc. Common Stock
Market Cap
$3.34M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
N/A
Market Cap
$3.33M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
25.00%
5Y Avg
50.00%
Market Cap
$3.28M
Gross Margin
36.10%
TTM Avg
40.19%
3Y Avg
41.87%
5Y Avg
47.28%
Market Cap
$3.25M
Gross Margin
16.54%
TTM Avg
-251.00%
3Y Avg
-125.05%
5Y Avg
-78.44%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cadrenal Therapeutics, Inc. Common Stock (CVKD) | $3.34M | 0.00% | 0.00% | 0.00% | N/A |
| Aethlon Medical, Inc. (AEMD)vs › | $3.33M | 0.00% | 0.00% | 25.00% | 50.00% |
| IceCure Medical Ltd (ICCM)vs › | $3.28M | 36.10% | 40.19% | 41.87% | 47.28% |
| Paranovus Entertainment Technology Ltd. (PAVS)vs › | $3.25M | 16.54% | -251.00% | -125.05% | -78.44% |
| Moolec Science S.A. (MLEC)vs › | $3.45M | 34.17% | 21.29% | 6.69% | 5.35% |
| Eocene Ltd. (EOCN)vs › | $3.42M | N/A | N/A | N/A | N/A |
| MBody AI Ltd. (MBAI)vs › | $3.17M | 0.00% | 0.00% | 0.00% | 0.00% |
| Mustang Bio, Inc. (MBIO)vs › | $3.49M | 0.00% | 0.00% | 0.00% | 0.00% |
| Evogene Ltd. (EVGN)vs › | $3.42M | -6.25% | 25.54% | 36.71% | 34.86% |
| Nexalin Technology, Inc. (NXL)vs › | $3.55M | 79.65% | 78.98% | 76.82% | 80.07% |
Gross Margin
0.0%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
